Activation of adenosine A1 receptors alters behavioral and biochemical parameters in hyperthyroid rats

Behavioural Brain Research

Volumn 167, Issue 2, 2006, Pages 287-294

  Bruno, Alessandra Nejar ^a   Fontella, Fernanda Urruth ^a   Bonan, Carla Denise ^b   Barreto Chaves, Maria Luiza M ^c   Dalmaz, Carla ^a   Sarkis, João José Freitas ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adenosine; Anxiety; CPA; Free radicals; Hyperthyroidism; Nociception

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; FREE RADICAL; LEVOTHYROXINE; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; HYPERALGESIA; HYPERTHYROIDISM; LOCOMOTION; MALE; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PARAMETER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ADENOSINE; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BRAIN; EXPLORATORY BEHAVIOR; HYPERTHYROIDISM; MALE; MOTOR ACTIVITY; OXIDATIVE STRESS; PAIN THRESHOLD; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 30744433328     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.09.017     Document Type: Article

References (42)

1. A.M. Adamo, S.F. Llesuy, J.M. Pasquini, and A. Boveris Brain chemiluminescence and oxidative stress in hyperthyroid rats Biochem J 263 1989 273 277
2. C.G. Almeida, A. De Mendonca, R.A. Cunha, and J.A. Ribeiro Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices Neurosci Lett 339 2003 127 130
3. R.F. Berman, B.B. Fredholm, U. Aden, and WT.O. Connor Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats Brain Res 872 2000 44 53
4. J. Beyer, M. Burke, D. Meglin, A. Fuller, K.R.R. Krishnan, and C.B. Nemeroff Organic anxiety disorder iatrogenic hyperthyroidism Psychosomatics 34 1993 181 184
5. J.M. Brundege, and T.V. Dunwiddie Role of adenosine as a modulator of synaptic activity in the central nervous system Adv Pharmacol 39 1997 353 391
6. A.N. Bruno, R.S. Da Silva, C.D. Bonan, A.M.O. Battastini, M.L. Barreto-chaves, and J.J.F. Sarkis Hyperthyroidism modifies ecto-nucleotidase activities in synaptosomes from hippocampus and cerebral cortex of rats in different phases of development Int J Dev Neurosci 21 2003 401 408
7. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol 52 1978 302 310
8. F.E. D'Amour, and D.L. Smith A method for determining of pain sensation J Pharmacol Exp Ther 72 1941 74 79
9. I.M. Coupar, and B.L. Tran Effects of adenosine agonists on consumptive behaviour and body temperature J Pharm Pharmacol 54 2002 289 294
10. A.S. Driver, P.R.S. Kodavanti, and W.R. Mundy Age-related in reactive oxygen species production in rat brain homogenates Neurotoxicol Teratol 22 2000 175 181
11. T.V. Dunwiddie, and S.A. Masino The role and regulation of adenosine in the central nervous system Annu Rev Neurosci 24 2001 31 55
12. G. Ehgstron, T.H. Svensson, and B. Waldeck Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensibility Brain Res 77 1974 471 483
13. M.D. Fideu, A. Arce, A.I. Esquifino, and M.T. Mras-Portugal Thyroid hormones modulate both adenosine transport and adenosine Al receptors in rat brain Am J Physiol 267 1994 C1651 C1656
14. C. Florio, A. Prezioso, A. Papaioannou, and R. Vertua Adenosine Al receptors modulate anxiety in CD1 mice Psychopharmacol (Berl) 136 1998 311 319
15. B.B. Fredholm Adenosine and neuroprotection Int Rev Neurobiol 40 1997 259 280
16. B.B. Fredholm, K. Bätig, J. Holmén, A. Nehlig, and E.F. Zvartau Action of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 1999 83 133
17. A.G. Gilman G proteins: transducers of receptor-generated signals Annu Rev Biochem 56 1987 615 649
18. 1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate Eur J Neurosci 16 2002 547 550
19. E.D. Hall The role of oxygen radicals in traumatic injury: clinical implications J Emerg Med 11 Suppl. 1 1993 31 36
20. B. Halliwell Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs Aging 18 2001 685 716
21. I. Izquierdo, N. Schroder, C.A. Netto, and J.H. Medina Novelty causes time-dependent retrograde amnesia for one-trial avoidance in rats through NMDA receptor- and CaMKII-dependent mechanisms in the hippocampus Eur J Neurosci 11 1999 3323 3328
22. M. Klinger, M. Freissmuth, and C. Nanoff Adenosine receptors: G protein-mediated signaling and the role of accessory proteins Cell Signal 14 2002 99 108
23. 1 adenosine receptors Naunyn Schmiedebergs Arch Pharmacol 340 1989 679 683
24. 3 homomeric and heteromeric channels in nociceptive signaling and behavior Drug Dev Res 52 2001 220 231
25. G.J. Keil 2nd, and G.E. DeLander Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice Eur J Pharmacol 271 1994 37 46
26. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J Neurochem 79 2001 463 484
27. E. Lissi, M. Salim-Hanna, C. Pascual, and M.D. del Castillo Evaluation of total antioxidant potential (TRAP) and total antioxidant reactivity from luminol-enhanced chemiluminescence measurements Free Radical Biol Med 18 1995 153 158
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
29. S.B. Maggirwar, D.N. Dhanraj, S.M. Somani, and V. Ramkumar Adenosine acts as an endogenous activator of the cellular antioxidant defense system Biochem Biophys Res Commun 201 1994 508 515
30. J.V. Martin, D.B. Williams, R.M. Fitzgerald, and P.F. Vonvoigtlander Thyroid hormonal modulation of the binding and activity of the GABAA receptor complex of brain Neuroscience 73 1996 705 713
31. C.A. Netto, B. Siegfried, and I. Izquierdo Analgesia induced by exposure to a novel environment in rats: effect of concurrent and post-training stressful stimulation Behav Neural Biol 48 1987 304 309
32. Z. Nie, Y. Mei, M. Ford, L. Rybak, A. Marcuzzi, and H. Ren Oxidative stress increases Al adenosine receptor expression by activating nuclear factor kappa B Mol Pharmacol 53 1998 663 669
33. R.M. Palmour, C.J. Lipowski, C.K. Simon, and F.R. Ervin Adenosine analogs inhibit fighting in isolated male mice Life Sci 44 1989 1293 1301
34. C.I. Pantos, I.S. Mourouzis, S.M. Tzeis, V. Malliopoulou, D.D. Cokkinos, and P. Asimacopoulos Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts J Cardiovasc Pharmacol 36 2000 384 389
35. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Neurosci Methods 14 1985 149 167
36. V. Ramkumar, D.M. Hallam, and Z. Nie Adenosine, oxidative stress and cytoprotection Jpn J Pharmacol 86 2001 265 274
37. A.J. Reeve, and A.H. Dickenson The role of spinal adenosine receptors in the control of acute and more persistent nociceptive response of dorsal horn neurones in the anaesthetized rats Br J Pharmacol 116 1995 2221 2228
38. M.W. Salter, Y. De Koninck, and J.L. Henry Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn Prog Neurobiol 41 1993 125 156
39. J. Sawynok Adenosine receptor activation and nociception Eur J Pharmacol 317 1998 1 11
40. J.W. Smith, A.T. Evans, B. Costall, and J.W. Smythe Thyroid hormones, brain function and cognition: a brief review Neurosci Biobehav Rev 26 2002 45 60
41. P.T. Trzepacz, I. Klein, M. Roberts, J. Greenhouse, and G.S. Levey Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms Am J Med 87 1989 558 561
42. H. Zimmermann Ectonucleotidases: some recent developments and note on nomenclature Drug Dev Res 52 2001 44 56